ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Medicamen Biotech Limited held its 33rd Annual General Meeting on September 26, 2026. The meeting concluded after discussing standard business and special resolutions.
Medicamen Biotech Limited filed its notice for the 33rd Annual General Meeting scheduled for September 26, 2026, alongside the Integrated Annual Report for FY 2025-26.
Medicamen Biotech Ltd reported revenue from operations of ₹4,790 Cr (+11.3% YoY) and net profit of ₹184.6 Cr (+15.3% YoY) for Q1 FY27.
Medicamen Biotech Ltd reported revenue from operations of ₹47.9 Cr (+11.4% YoY) and net profit of ₹1.8 Cr (+12.5% YoY) for Q1 FY27.